JEANNIE BROOKS: Open Payments
NPI 1407963374 · LAWRENCEBURG, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 35 payments from 8 companies in 2025. Trend: 2023 $1,585 · 2024 $2,532 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $205 |
| Lundbeck LLC | 6 | $139 |
| Neurocrine BioSciences, Inc. | 5 | $125 |
| Alkermes, Inc. | 2 | $56 |
| ABBVIE INC. | 3 | $49 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: REXULTI, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, ARISTADA, VRAYLAR, Qelbree, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
